BEGIN:VCALENDAR VERSION:2.0 PRODID:-//PYVOBJECT//NONSGML Version 1//EN BEGIN:VTIMEZONE TZID:Europe/Berlin BEGIN:STANDARD DTSTART:20001029T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10 TZNAME:CET TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:20000326T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3 TZNAME:CEST TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:20260521T065151Z - 97177@eupp247 DTSTART;TZID=Europe/Berlin:20220209T150000 DTEND;TZID=Europe/Berlin:20220209T160000 CREATED:20260521T065151Z DESCRIPTION:Non invasive cortical stimulation for chronic pain: from anecdote to evidence< /a>\nThis webinar has ended. Stay tuned for similar events on this topic! Welcome to ANT Neuro Educational Webinar Series! Repetitive transcranial m agnetic stimulation (rTMS) first developed as a means of predicting the ef ficacy of neurosurgical procedures of cortical stimulation\, then rapidly as an analgesic method on its own right. Reasonable evidence from at least 6 well-conducted controlled studies indicates a significant short-term an algesic effect of high-frequency rTMS of the motor cortex in neuropathic p ain\, and less consistently in widespread/fibromyalgic pain. Stimulation o f the dorsolateral frontal cortex (DLPFC) has not proven efficacious for p ain\, so far. The operculo-insular cortex is a new and attractive target b ut evidence remains insufficient. rTMS exerts its effects through multiple parallel and distributed brain networks influencing simultaneously the se nsory\, affective and cognitive aspects of chronic pain. Its effects devel op predominantly upon abnormally sensitised pathways\, rather than on acut e experimental pain. Transcranial direct current stimulation (tDCS) is an alternative procedure aimed at similar targets as rTMS\, with the possibil ity of home-based protocols. However\, the limited quality of most publish ed tDCS reports makes the level of evidence still very low. Although the s hort-term efficacy of rTMS in neuropathic pain can be achieved with NNT ~2 -3\, extending the duration of beneficial effects during months of years² remains its most significant challenge\, for which different strategies a re being currently proposed\, and will be discussed. This will be presente d by Prof. Dr. Luis Garcia-Larrea who is the Research Director at the INSE RM\, Head of the Inserm/University research Lab “Central Integration of Pain in Humans” (NeuroPain) at the Lyon Centre for Neuroscience\, and pr actitioner at the Pain Clinic in Lyon Neurological Hospital. We [...] DTSTAMP:20260521T065151Z LOCATION:Online SUMMARY:Noninvasive cortical stimulation for chronic pain: from anecdote to evidence X-ALT-DESC;FMTTYPE=text/html:Noninvasive cortical stimulation for chronic pain: from anec dote to evidence\nThis webinar has ended. Stay tuned for similar event s on this topic! Welcome to ANT Neuro Educational Webinar Series! Repetiti ve transcranial magnetic stimulation (rTMS) first developed as a means of predicting the efficacy of neurosurgical procedures of cortical stimulatio n\, then rapidly as an analgesic method on its own right. Reasonable evide nce from at least 6 well-conducted controlled studies indicates a signific ant short-term analgesic effect of high-frequency rTMS of the motor cortex in neuropathic pain\, and less consistently in widespread/fibromyalgic pa in. Stimulation of the dorsolateral frontal cortex (DLPFC) has not proven efficacious for pain\, so far. The operculo-insular cortex is a new and at tractive target but evidence remains insufficient. rTMS exerts its effects through multiple parallel and distributed brain networks influencing simu ltaneously the sensory\, affective and cognitive aspects of chronic pain. Its effects develop predominantly upon abnormally sensitised pathways\, ra ther than on acute experimental pain. Transcranial direct current stimulat ion (tDCS) is an alternative procedure aimed at similar targets as rTMS\, with the possibility of home-based protocols. However\, the limited qualit y of most published tDCS reports makes the level of evidence still very lo w. Although the short-term efficacy of rTMS in neuropathic pain can be ach ieved with NNT ~2-3\, extending the duration of beneficial effects during months of years² remains its most significant challenge\, for which diffe rent strategies are being currently proposed\, and will be discussed. This will be presented by Prof. Dr. Luis Garcia-Larrea who is the Research Dir ector at the INSERM\, Head of the Inserm/University research Lab “Centra l Integration of Pain in Humans” (NeuroPain) at the Lyon Centre for Neur oscience\, and practitioner at the Pain Clinic in Lyon Neurological Hospit al. We [...] END:VEVENT END:VCALENDAR